Seeing Is Believing
with an average price target of $652.69. This is a potential upside of $651.32 (47541.61%) from yesterday's end of day stock price of $1.37.
Galmed Pharmaceuticals Ltd's activity chart (see below) currently has 14 price targets and 33 ratings on display.
Analysts average stock forecasts to be materialized ratio is 44.44% with an average time for these price targets to be met of 432.33 days.
Most recent stock forecast was given by JASON MCCARTHY from MAXIM GROUP on 23-Jul-2023. First documented stock forecast 08-Jul-2015.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$48
$46.62 (3378.26%)
2 years 3 months 9 days ago
(23-Jul-2023)
1/2 (50%)
$33.48 (230.58%)
89
Buy
3 years 2 months 25 days ago
(07-Aug-2022)
0/2 (0%)
$4172.4 (398.28%)
Buy
$13
3 years 2 months 28 days ago
(04-Aug-2022)
2/2 (100%)
$-34.55 (-72.66%)
291
Hold
3 years 5 months 15 days ago
(17-May-2022)
1/2 (50%)
$-541.2 (-59.07%)
580
Hold
3 years 5 months 15 days ago
(17-May-2022)
1/2 (50%)
$1481.4 (84.24%)
2101
What is GLMD (Galmed Pharmaceuticals Ltd) average time for price targets to be met?
Which analyst has the current highest performing score on GLMD (Galmed Pharmaceuticals Ltd) with a proven track record?
Which analyst has the current lower performing score on GLMD (Galmed Pharmaceuticals Ltd) with a proven track record?
Which analyst has the most public recommendations on GLMD (Galmed Pharmaceuticals Ltd)?
Which analyst is the currently most bullish on GLMD (Galmed Pharmaceuticals Ltd)?
Which analyst is the currently most reserved on GLMD (Galmed Pharmaceuticals Ltd)?